Gross Margin - Genpharmasec Ltd (BSE:531592) - Alpha Spread
G

Genpharmasec Ltd
BSE:531592

Watchlist Manager
Genpharmasec Ltd
BSE:531592
Watchlist
Price: 3.05 INR 0.33% Market Closed
Market Cap: 1.7B INR
Have any thoughts about
Genpharmasec Ltd?
Write Note

Gross Margin
Genpharmasec Ltd

20.3%
Current
11%
Average
19.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
20.3%
=
Gross Profit
61.7m
/
Revenue
304.1m

Gross Margin Across Competitors

Country IN
Market Cap 1.6B INR
Gross Margin
20%
Country JP
Market Cap 12.5T JPY
Gross Margin
12%
Country JP
Market Cap 11.4T JPY
Gross Margin
16%
Country JP
Market Cap 9.7T JPY
Gross Margin
10%
Country US
Market Cap 53.9B USD
Gross Margin
41%
Country US
Market Cap 50.8B USD
Gross Margin
39%
Country IN
Market Cap 3.6T INR
Gross Margin
49%
Country US
Market Cap 41B USD
Gross Margin
45%
Country UK
Market Cap 40.8B USD
Gross Margin
31%
Country UK
Market Cap 25.7B GBP
Gross Margin
75%
Country US
Market Cap 28.7B EUR
Gross Margin
39%

Profitability Report

View the profitability report to see the full profitability analysis for Genpharmasec Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
20.3%
=
Gross Profit
61.7m
/
Revenue
304.1m
What is the Gross Margin of Genpharmasec Ltd?

Based on Genpharmasec Ltd's most recent financial statements, the company has Gross Margin of 20.3%.